Search
Halozyme Therapeutics Inc
HALOAdd to Watchlist
82.540USD
-0.760-0.91%
Close 07-31 16:00（ET）Quotes delayed by 15 min
9.79BMarket Cap
27.92P/E TTM
Halozyme Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Halozyme Therapeutics Inc is 7.16, ranking 121 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 27.92, which is 35.04% below the recent high of 37.71 and 58.41% above the recent low of 11.61.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.